無料プレビュー

Catalent, Inc. (CTLT) · New York Stock Exchange

プロフィール

Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are util

主要指標

株価: $63.48 (0.00%)
時価総額: 115億ドル
PER（今期予想）: 59.2
PBR: 3.2
配当利回り: —
52週レンジ: $42.11 – $63.50
業種: Healthcare / Drug Manufacturers - Specialty & Generic
上場: New York Stock Exchange
構成銘柄: —

比較会社: TAK Takeda Pharmaceutical Company Limited、BDX Becton, Dickinson and Company、TEVA Teva Pharmaceutical Industries Limited、HLN Haleon plc、ZTS Zoetis Inc.、VTRS Viatris Inc.、RVTY Revvity, Inc.、ITCI Intra-Cellular Therapies, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

更新: 2026-10-09